Advertisement

Topics

Global Glucagon Like Peptide1 GLP1 Agonists Market Data Survey Report 2025 [Report Updated: 31102017] Prices from USD $1500

05:51 EST 10 Nov 2017 | BioPortfolio Reports

Summary

Glucagon like peptide1 GLP1 agonists is the agonists of the GLP1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

The global Glucagon Like Peptide1 GLP1 Agonists market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export import

Key manufacturers manufacturing sites, capacity and production, product specifications etc.

Average market price by SUK

Major applications

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

Novo Nordisk

AstraZeneca

Eli Lily

GSK

Sanofi

BristolMyers Squibb

Amylin

Major applications as follows:

Hospital

Pharmacy

Others

Regional market size, production data and export import:

AsiaPacific

North America

Europe

South America

Middle East Africa

Original Article: Global Glucagon Like Peptide1 GLP1 Agonists Market Data Survey Report 2025 [Report Updated: 31102017] Prices from USD $1500

NEXT ARTICLE

More From BioPortfolio on "Global Glucagon Like Peptide1 GLP1 Agonists Market Data Survey Report 2025 [Report Updated: 31102017] Prices from USD $1500"

Advertisement
Quick Search
Advertisement
Advertisement